263 related articles for article (PubMed ID: 17484876)
1. Potentiation of oxyntic atrophy-induced gastric metaplasia in amphiregulin-deficient mice.
Nam KT; Varro A; Coffey RJ; Goldenring JR
Gastroenterology; 2007 May; 132(5):1804-19. PubMed ID: 17484876
[TBL] [Abstract][Full Text] [Related]
2. Alterations in gastric mucosal lineages induced by acute oxyntic atrophy in wild-type and gastrin-deficient mice.
Nomura S; Yamaguchi H; Ogawa M; Wang TC; Lee JR; Goldenring JR
Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G362-75. PubMed ID: 15647607
[TBL] [Abstract][Full Text] [Related]
3. Altered metaplastic response of waved-2 EGF receptor mutant mice to acute oxyntic atrophy.
Ogawa M; Nomura S; Varro A; Wang TC; Goldenring JR
Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G793-804. PubMed ID: 16306133
[TBL] [Abstract][Full Text] [Related]
4. Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia.
Nam KT; Lee HJ; Mok H; Romero-Gallo J; Crowe JE; Peek RM; Goldenring JR
Gastroenterology; 2009 Apr; 136(4):1288-96. PubMed ID: 19230855
[TBL] [Abstract][Full Text] [Related]
5. A molecular signature of gastric metaplasia arising in response to acute parietal cell loss.
Nozaki K; Ogawa M; Williams JA; Lafleur BJ; Ng V; Drapkin RI; Mills JC; Konieczny SF; Nomura S; Goldenring JR
Gastroenterology; 2008 Feb; 134(2):511-22. PubMed ID: 18242217
[TBL] [Abstract][Full Text] [Related]
6. Altered gastric chief cell lineage differentiation in histamine-deficient mice.
Nozaki K; Weis V; Wang TC; Falus A; Goldenring JR
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1211-20. PubMed ID: 19359424
[TBL] [Abstract][Full Text] [Related]
7. Alterations in gastric mucosal lineages before or after acute oxyntic atrophy in gastrin receptor and H2 histamine receptor-deficient mice.
Aikou S; Fukushima Y; Ogawa M; Nozaki K; Saito T; Matsui T; Goldenring JR; Kaminishi M; Nomura S
Dig Dis Sci; 2009 Aug; 54(8):1625-35. PubMed ID: 19507031
[TBL] [Abstract][Full Text] [Related]
8. Spasmolytic polypeptide-expressing metaplasia (SPEM) in the gastric oxyntic mucosa does not arise from Lgr5-expressing cells.
Nam KT; O'Neal RL; Coffey RJ; Finke PE; Barker N; Goldenring JR
Gut; 2012 Dec; 61(12):1678-85. PubMed ID: 22198711
[TBL] [Abstract][Full Text] [Related]
9. Loss of HGF activator inhibits foveolar hyperplasia induced by oxyntic atrophy without altering gastrin levels.
Yamagata Y; Aikou S; Fukushima T; Kataoka H; Seto Y; Esumi H; Kaminishi M; Goldenring JR; Nomura S
Am J Physiol Gastrointest Liver Physiol; 2012 Dec; 303(11):G1254-61. PubMed ID: 23064758
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of the gastric mucosa III. Animal models of oxyntic atrophy and metaplasia.
Goldenring JR; Nomura S
Am J Physiol Gastrointest Liver Physiol; 2006 Dec; 291(6):G999-1004. PubMed ID: 17090722
[TBL] [Abstract][Full Text] [Related]
11. Association of spasmolytic polypeptide-expressing metaplasia with carcinogen administration and oxyntic atrophy in rats.
Yamaguchi H; Goldenring JR; Kaminishi M; Lee JR
Lab Invest; 2002 Aug; 82(8):1045-52. PubMed ID: 12177243
[TBL] [Abstract][Full Text] [Related]
12. Macrophages promote progression of spasmolytic polypeptide-expressing metaplasia after acute loss of parietal cells.
Petersen CP; Weis VG; Nam KT; Sousa JF; Fingleton B; Goldenring JR
Gastroenterology; 2014 Jun; 146(7):1727-38.e8. PubMed ID: 24534633
[TBL] [Abstract][Full Text] [Related]
13. Decrease in MiR-148a Expression During Initiation of Chief Cell Transdifferentiation.
Shimizu T; Sohn Y; Choi E; Petersen CP; Prasad N; Goldenring JR
Cell Mol Gastroenterol Hepatol; 2020; 9(1):61-78. PubMed ID: 31473306
[TBL] [Abstract][Full Text] [Related]
14. Omeprazole treatment ameliorates oxyntic atrophy induced by DMP-777.
Ogawa M; Nomura S; Car BD; Goldenring JR
Dig Dis Sci; 2006 Mar; 51(3):431-9. PubMed ID: 16614949
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression.
Weis VG; Sousa JF; LaFleur BJ; Nam KT; Weis JA; Finke PE; Ameen NA; Fox JG; Goldenring JR
Gut; 2013 Sep; 62(9):1270-9. PubMed ID: 22773549
[TBL] [Abstract][Full Text] [Related]
16. Maturity and age influence chief cell ability to transdifferentiate into metaplasia.
Weis VG; Petersen CP; Weis JA; Meyer AR; Choi E; Mills JC; Goldenring JR
Am J Physiol Gastrointest Liver Physiol; 2017 Jan; 312(1):G67-G76. PubMed ID: 27881402
[TBL] [Abstract][Full Text] [Related]
17. Reversible drug-induced oxyntic atrophy in rats.
Goldenring JR; Ray GS; Coffey RJ; Meunier PC; Haley PJ; Barnes TB; Car BD
Gastroenterology; 2000 Jun; 118(6):1080-93. PubMed ID: 10833483
[TBL] [Abstract][Full Text] [Related]
18. WFDC2 Promotes Spasmolytic Polypeptide-Expressing Metaplasia Through the Up-Regulation of IL33 in Response to Injury.
Jeong H; Lee B; Kim KH; Cho SY; Cho Y; Park J; Lee Y; Oh Y; Hwang BR; Jang AR; Park JH; Park JH; Jeong SH; Lee D; Lee YC; Lim KM; Goldenring JR; Nam KT
Gastroenterology; 2021 Sep; 161(3):953-967.e15. PubMed ID: 34116028
[TBL] [Abstract][Full Text] [Related]
19. Emergence of spasmolytic polypeptide-expressing metaplasia in Mongolian gerbils infected with Helicobacter pylori.
Yoshizawa N; Takenaka Y; Yamaguchi H; Tetsuya T; Tanaka H; Tatematsu M; Nomura S; Goldenring JR; Kaminishi M
Lab Invest; 2007 Dec; 87(12):1265-76. PubMed ID: 18004396
[TBL] [Abstract][Full Text] [Related]
20. Current understanding of SPEM and its standing in the preneoplastic process.
Weis VG; Goldenring JR
Gastric Cancer; 2009; 12(4):189-97. PubMed ID: 20047123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
